{
  "prompt": {
    "guidelineId": "cg1116-fetal-heart-monitoring-sampling-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 7813
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"**Fetal Heart Monitoring Guidelines for Antenatal and Intrapartum Care**\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Heart Monitoring Guidelines:** - **Monitoring Methods:** Use intermittent auscultation (Pinard’s stethoscope) for low-risk pregnancies and continuous electronic fetal monitoring (CEFM) for high-risk cases (e.g., hypertension, breech, antepartum hemorrhage). - **Antenatal Monitoring:** Apply Dawes-Redman Criteria from 26 weeks; discontinue after 10 minutes if met; seek obstetric review if not met by 60 minutes. - **Intrapartum Monitoring:** Regular CTG review, considering maternal/fetal risk factors. Escalate concerns promptly for abnormal traces. - **Fetal Blood Sampling (FBS):** Consider for pathological CTG if no contraindications (e.g., acute fetal compromise, sepsis, bleeding disorders, prematurity <34 weeks). Avoid if expedited birth is needed. - **Cord Blood Sampling:** Perform if fetal concerns arise during labor or birth, especially for SGA/FGR cases. Paired samples (artery/vein) should be analyzed promptly; document results. - **CTG Troubleshooting:** Address poor signal by repositioning transducers, using fetal scalp electrodes, or switching machines. - **Human Factors & Documentation:** Ensure clear communication, document CTG findings, and store traces for 25 years. - **Care Analysis (FM800E):** Use antenatally only; requires 10 minutes of quality data. Results guide but do not replace clinical judgment. *Key: Prioritize maternal preferences, clinical context, and timely intervention.* (200 words)\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T21-42-53",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1116-fetal-heart-monitoring-sampling-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 7813\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"**Fetal Heart Monitoring Guidelines for Antenatal and Intrapartum Care**\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Heart Monitoring Guidelines:** - **Monitoring Methods:** Use intermittent auscultation (Pinard’s stethoscope) for low-risk pregnancies and continuous electronic fetal monitoring (CEFM) for high-risk cases (e.g., hypertension, breech, antepartum hemorrhage). - **Antenatal Monitoring:** Apply Dawes-Redman Criteria from 26 weeks; discontinue after 10 minutes if met; seek obstetric review if not met by 60 minutes. - **Intrapartum Monitoring:** Regular CTG review, considering maternal/fetal risk factors. Escalate concerns promptly for abnormal traces. - **Fetal Blood Sampling (FBS):** Consider for pathological CTG if no contraindications (e.g., acute fetal compromise, sepsis, bleeding disorders, prematurity <34 weeks). Avoid if expedited birth is needed. - **Cord Blood Sampling:** Perform if fetal concerns arise during labor or birth, especially for SGA/FGR cases. Paired samples (artery/vein) should be analyzed promptly; document results. - **CTG Troubleshooting:** Address poor signal by repositioning transducers, using fetal scalp electrodes, or switching machines. - **Human Factors & Documentation:** Ensure clear communication, document CTG findings, and store traces for 25 years. - **Care Analysis (FM800E):** Use antenatally only; requires 10 minutes of quality data. Results guide but do not replace clinical judgment. *Key: Prioritize maternal preferences, clinical context, and timely intervention.* (200 words)\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}